Keywords: novartis, files, eu, approval, xolair, pharma, ag

Novartis files for EU approval of Xolair

Article | 12 July 2004

Print This

Novartis Pharma AG has submitted an application for European approval ofXolair (omalizumab), which targets a root cause of allergic disease ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in